Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Surgical management of vaginal mesh erosion: an alternative to excision.

Shaker D.

Case Report / Series, published in Int Urogynecol J (2009) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Int Urogynecol J (2009)
Country
England
Reported sample size
—
Source database
PubMed
PMID
19812876
DOI
10.1007/s00192-009-1009-4

Abstract (original English)

HYPOTHESIS AND INTRODUCTION: Management of vaginal mesh erosion can be conservative, but in a large proportion of patients, excision/trimming of the mesh is needed. This paper describes a technique using an intervening vulval pad of fat graft between the vaginal epithelium and the mesh as an alternative to excision. Three cases are presented where vaginal mesh erosion was treated using an intervening vulval pad of fat as a graft to cover polypropylene mesh erosion, and the technique is described. There were no intraoperative complications. All patients reported no further symptoms at follow-up, and examination revealed no further mesh erosions. The use of intervening graft of vulval fat can be an alternative to excision in the management of patients with vaginal mesh erosion.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAgedFemaleHumansMiddle AgedReoperationSurgical MeshTissue TransplantationUterine ProlapseVagina

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.